UL Acquires Emergo to Expand Medical Device Regulatory Services

April 25, 2017

UL (Underwriters Laboratories) has acquired Emergo, an Austin-based regulatory services firm for medical device manufacturers, expanding UL's health sciences regulatory and market access capabilities. Emergo's headquarters and more than 200 employees will be retained as UL integrates Emergo's device registration expertise to accelerate global market access for customers.

Buyers
UL (Underwriters Laboratories)
Targets
Emergo
Industry
Medical Devices
Location
Texas, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.